(Q73694955)

English

YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)urea]: an irreversible cholecystokinin type-B receptor antagonist

scientific article published on 01 July 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)urea]: an irreversible cholecystokinin type-B receptor antagonist (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

cholecystokinin

1 reference

based on heuristic

inferred from title

author name string

J Dunlop

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

N Brammer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

N Evans

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

C Ennis

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

0 references

publication date

1 July 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

54

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

81-85

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900139-1

7 January 2021

A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900139-1

7 January 2021

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900139-1

7 January 2021

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900139-1

7 January 2021

Characterization of cloned human cholecystokinin-B receptor as a gastrin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900139-1

7 January 2021

Characterization of YM022: its CCKB/gastrin receptor binding profile and antagonism to CCK-8-induced Ca2+ mobilization

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900139-1

7 January 2021

Pharmacological characterization of a Chinese hamster ovary cell line transfected with the human CCK-B receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900139-1

7 January 2021

Tetronothiodin, a novel CCKB receptor ligand, antagonizes cholecystokinin-induced Ca2+ mobilization in a pituitary cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900139-1

7 January 2021

Characterization of the novel CCK analogs JMV-180, JMV-320, and JMV-332 in H345 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900139-1

7 January 2021

Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900139-1

7 January 2021

The cytosensor microphysiometer: biological applications of silicon technology

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900139-1

7 January 2021

Identifiers

10.1016/S0006-2952(97)00139-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9296353%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73694955&oldid=1984919157"